Has Whitney McCullough received payments from drug or device companies?

Yes. Drug and device makers reported $3,348 in general payments to Whitney McCullough across 112 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Whitney McCullough did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Whitney McCullough come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Whitney McCullough

Medical · Bradenton, FLNPI 1265071211

Payments from drug & device makers

$3,348in general payments, 2019–2025

Across 112 payments — averaging $29.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

GSK$663
Sanofi$458
AstraZeneca$394
Regeneron Healthcare Solutions, Inc.$349
Takeda Pharmaceuticals U.S.A., Inc.$192
Genentech USA, Inc.$183
plus $1K from 19 others

What the payments were for

Consulting fees$231%
Food & beverage$3,24597%
Education$802%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
GSK	25	$663
Sanofi	13	$458
AstraZeneca	11	$394
Regeneron Healthcare Solutions, Inc.	11	$349
Takeda Pharmaceuticals U.S.A., Inc.	10	$192
Genentech USA, Inc.	4	$183
CSL Behring	6	$164
Galderma Laboratories, L.p.	2	$130
Biocryst US Sales Co., LLC	1	$110
Novartis	3	$92
ARS Pharmaceuticals Operations, Inc.	3	$80
Grifols USA, LLC	3	$71
Pfizer	3	$70
AbbVie	2	$52
Optinose US, Inc.	2	$50
Alk-abello, Inc	1	$47
Greer Laboratories, Inc.	2	$46
Pharming Healthcare, Inc.	2	$36
Hikma Pharmaceuticals USA	2	$33
Insmed, Inc.	1	$31
ADMA Biomanufacturing LLC	1	$23
Azurity Pharmaceuticals, Inc.	1	$22
Ionis Pharmaceuticals, Inc.	1	$19
Aimmune Therapeutics, Inc.	1	$18
Blueprint Medicines Corporation	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,348 in reported general payments places this provider in the 80th percentile of 2,031 medical providers in Florida.

See all medical providers in Florida →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter	51	$44,781
Spiriva RespimatTiotropium Bromide	30	$18,238
Advair HfaFluticasone Propion/Salmeterol	11	$10,323
Arnuity ElliptaFluticasone Furoate	22	$6,909
Incruse ElliptaUmeclidinium Bromide	14	$5,010
Epinephrine	34	$4,234
Qvar RedihalerBeclomethasone Dipropionate	12	$3,424
Azelastine Hcl	86	$2,230
Mometasone Furoate	13	$2,159
Ipratropium Bromide	74	$1,642
Albuterol Sulfate HfaAlbuterol Sulfate	50	$1,577
Fluticasone-SalmeterolFluticasone Propion/Salmeterol	12	$1,552
Fluticasone Propionate	113	$1,523
Asmanex HfaMometasone Furoate	15	$1,512
Levocetirizine Dihydrochloride	96	$1,393

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
GSKTrelegy Ellipta, Arnuity Ellipta, Incruse Ellipta	$663	$56,70187 claims
Hikma Pharmaceuticals USAEpinephrine	$33	$4,23434 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,031 medical providers in Florida.

Other medical in Bradenton

Gary RubinRockledge$2.1M
Shanna MirantiNaples$415K
Krystie LennoxBoca Raton$245K
Jihan RamadanWellington$238K
Ilanit SamuelsMiami$211K
Erin DouceyWinter Haven$202K
Kathleen TrummerWellington$166K
Sandra SnyderTampa$156K
Francine PhillipsLand O Lakes$145K
Chelsie FerrellDeland$132K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →